ArticleTheranostics2026
Structure-based redesign enables clinical translation of CAIX-targeted theranostics in clear cell renal cell carcinoma.
Zexin Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it